Hikma MENA licensing head says partnerships expand pipeline via in-licensed products

• In an employee interview, Hikma executive Lama Shatara outlined a MENA licensing strategy focused on in-licensing products it cannot develop internally.
• Pipeline sourcing centers on scouting partners, evaluating registration and commercialization potential, then negotiating licensing agreements to add products in-region.
• She said alliance management continues post-signing, with renewals, territory expansions, or added products used to sustain long-term partnership value.
• Shatara highlighted a preference for complex generics requiring capabilities outside Hikma’s manufacturing network, positioning partnerships as a key growth lever.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hikma Pharmaceuticals plc published the original content used to generate this news brief on October 05, 2026, and is solely responsible for the information contained therein.